I1SCHEDULE 2DRUGS ON MEDICINES TO BE ORDERED ONLY IN CERTAIN CIRCUMSTANCES

Regulation 3

Annotations:
Commencement Information
I1

Sch. 2 in force at 1.4.2004, see reg. 1(1)

Column 1

Column 2

Column 3

Drugs

Patient

Condition

Clobazam

Any patient

Treatment of epilepsy

Cyanocobalamin Tablets

A patient who is a vegan or who has a proven vitamin B12 deficiency of dietary origin

Treatment or prevention of vitamin B12 deficiency

Locabiotal Aerosol

Any patient

Treatment of infections and inflammation of the oropharynx

Niferex Elixir 30ml Paediatric Dropper Bottle

Infants born prematurely

Prophylaxis and treatment of iron deficiency

Nizoral Cream

Any patient

Treatment of seborrhoeic dermatitis and pityriasis versicolor

The following drugs for the treatment of erectile dysfunction—

Alprostadil (Caverject), (MUSE), (Viridal)

Apomorphine Hydrochloride (Uprima)

Moxisylyte Hydrochloride (Erecnos)

Sildenafil (Viagra)

Tadalafil (Cialis)

Thymoxamine Hydrochloride (Erecnos)

Vardenafil (Levitra)

a

a man with erectile dysfunction who on 14th September 1998 was receiving a course of treatment under the Act, the National Health Service (Scotland) Act 19783 or the Health and Personal Social Services (Northern Ireland) Order 19724 for this condition with any of the following drugs—

  • Alprostadil (Caverject), (MUSE), (Viridal)

  • Apomorphine Hydrochloride (Uprima)

  • Moxisylyte Hydrochloride Assembly (Erecnos)

  • Sildenafil (Viagra)

  • Tadalafil (Cialis)

  • Thymoxamine Hydrochloride (Erecnos); or

b

man who is a national of an EEA State who is entitled to treatment by virtue of Article 7(2) of Council Regulation 1612/685 as extended by the EEA Agreement or by virtue of any other enforceable Community right who has erectile dysfunction and was on 14th September 1998 receiving a course of treatment under a national health insurance system of an EEA State for this condition with any of the drugs listed in sub-paragraph (a); or

c

a man who is not a national of an EEA State but who is the member of the family of such a national who has an enforceable Community right to be treated no less favourably than the national in the provision of medical treatment and has erectile dysfunction and was being treated for that condition on 14th September 1998 with any of the drugs listed in sub-paragraph (a); or

d

a man who is suffering from any of the following—

  • diabetes

  • multiple sclerosis

  • parkinson’s disease

  • poliomyelitis

  • prostate cancer

  • severe pelvic injury

  • single gene

  • neurological disease

  • spina bifida

  • spinal cord injury; or

e

a man who is receiving treatment for renal failure by dialysis; or

f

a man who has had the following surgery —

  • prostatectomy

  • radical pelvic surgery

  • renal failure treated by transplant

Treatment of erectile dysfunction

In this Schedule—

  • “EEA Agreement” means the Agreement on the European Economic Area signed at Oporto on 2nd May 19926 as adjusted by the Protocol signed at Brussels on 17th March 19937 and as amended so far as is relevant to these Regulations, by Decision of the EEA Joint Committee No 7/94 of 21st March 19948;

  • “EEA State” means a State which is a contracting party to the EEA Agreement or Switzerland.